Overview

Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects

Status:
Completed
Trial end date:
2017-06-02
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and tolerability of TOP1288 oral single ascending and multiple doses in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Topivert Pharma Ltd